Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1990 1
1991 1
1992 1
1993 1
1995 1
1997 2
2000 3
2001 2
2002 3
2003 4
2004 4
2005 3
2006 3
2007 4
2008 8
2009 5
2010 9
2011 11
2012 7
2013 7
2014 6
2015 8
2016 12
2017 5
2018 8
2019 9
2020 4
2021 3
2022 5
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA. Ullmann AJ, et al. Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12. Clin Microbiol Infect. 2018. PMID: 29544767 Free article.
Chest computed tomography as well as bronchoscopy with bronchoalveolar lavage (BAL) in patients with suspicion of pulmonary invasive aspergillosis (IA) are strongly recommended. For diagnosis, direct microscopy, preferably using optical brighteners, histopathology and cult …
Chest computed tomography as well as bronchoscopy with bronchoalveolar lavage (BAL) in patients with suspicion of pulmonary invasive …
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, Kiehl M, Koldehoff M, Krause SW, Lehners N, von Lilienfeld-Toal M, Löhnert AY, Maschmeyer G, Teschner D, Ullmann AJ, Penack O, Ruhnke M, Mayer K, Ostermann H, Wolf HH, Cornely OA. Mellinghoff SC, et al. Ann Hematol. 2018 Feb;97(2):197-207. doi: 10.1007/s00277-017-3196-2. Epub 2017 Dec 7. Ann Hematol. 2018. PMID: 29218389 Free PMC article. Review.
Immunocompromised patients are at high risk of invasive fungal infections (IFI), in particular those with haematological malignancies undergoing remission-induction chemotherapy for acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS) and recipients of al …
Immunocompromised patients are at high risk of invasive fungal infections (IFI), in particular those with haematological malig …
Contemporary Strategies in the Prevention and Management of Fungal Infections.
Koehler P, Cornely OA. Koehler P, et al. Infect Dis Clin North Am. 2016 Mar;30(1):265-75. doi: 10.1016/j.idc.2015.10.003. Epub 2015 Dec 29. Infect Dis Clin North Am. 2016. PMID: 26739606 Review.
Major patient groups at risk for invasive fungal infection are found in hematology, intensive care, and abdominal surgery units. The vast majority of invasive fungal infections are candidemia, pulmonary aspergillosis, and pulmonary or sin …
Major patient groups at risk for invasive fungal infection are found in hematology, intensive care, and abdomina …
Invasive fungal infections during the neonatal period: diagnosis, treatment and prophylaxis.
Tezer H, Canpolat FE, Dilmen U. Tezer H, et al. Expert Opin Pharmacother. 2012 Feb;13(2):193-205. doi: 10.1517/14656566.2012.647685. Epub 2012 Jan 6. Expert Opin Pharmacother. 2012. PMID: 22220691 Review.
AREAS COVERED: The present article reviews the diagnosis, treatment and prophylaxis of invasive fungal infections (IFIs) during the neonatal period. IFIs are associated with high morbidity and mortality in preterm neonates. ...EXPERT OPINION: Invasive-fung …
AREAS COVERED: The present article reviews the diagnosis, treatment and prophylaxis of invasive fungal infections (IFIs) durin …
Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.
Falcone EL, Holland SM. Falcone EL, et al. Curr Opin Infect Dis. 2012 Dec;25(6):658-69. doi: 10.1097/QCO.0b013e328358b0a4. Curr Opin Infect Dis. 2012. PMID: 22964947 Review.
PURPOSE OF REVIEW: Invasive fungal infections (IFIs) remain a major cause of death in patients with chronic granulomatous disease (CGD). We discuss the new insights into the pathogenesis, diagnosis, prevention, and management of invasive fungal infecti …
PURPOSE OF REVIEW: Invasive fungal infections (IFIs) remain a major cause of death in patients with chronic granulomatous dise …
Prevention and treatment of invasive fungal infection in very low birthweight infants.
Brecht M, Clerihew L, McGuire W. Brecht M, et al. Arch Dis Child Fetal Neonatal Ed. 2009 Jan;94(1):F65-9. doi: 10.1136/adc.2007.133769. Epub 2008 Oct 6. Arch Dis Child Fetal Neonatal Ed. 2009. PMID: 18838467 Review.
Invasive fungal infection is an important cause of mortality and morbidity in very low birthweight (VLBW) infants. ...However, although systemic antifungal prophylaxis reduces the incidence of invasive fungal infection, there is no eviden …
Invasive fungal infection is an important cause of mortality and morbidity in very low birthweight (VLBW) infants. ...H …
Definition and management of invasive fungal rhinosinusitis: a single-centre retrospective study.
Fadda GL, Martino F, Andreani G, Succo G, Catalani M, Di Girolamo S, Cavallo G. Fadda GL, et al. Acta Otorhinolaryngol Ital. 2021 Feb;41(1):43-50. doi: 10.14639/0392-100X-N0848. Acta Otorhinolaryngol Ital. 2021. PMID: 33746222 Free PMC article.
OBJECTIVES: The purpose of this study was to correlate acute invasive fungal rhinosinusitis (AIFRS) and chronic invasive fungal rhinosinusitis with underlying diseases, aetiological microorganisms, clinical symptoms, radiological findings, and surgical …
OBJECTIVES: The purpose of this study was to correlate acute invasive fungal rhinosinusitis (AIFRS) and chronic invasive …
Azole antifungals: 35 years of invasive fungal infection management.
Allen D, Wilson D, Drew R, Perfect J. Allen D, et al. Expert Rev Anti Infect Ther. 2015 Jun;13(6):787-98. doi: 10.1586/14787210.2015.1032939. Epub 2015 Apr 5. Expert Rev Anti Infect Ther. 2015. PMID: 25843556 Review.
Prior to 1981, treatment options for invasive fungal infections were limited and associated with significant toxicities. The introduction of ketoconazole marked the beginning of an era of dramatic improvements over previous therapies for non-life-threatening …
Prior to 1981, treatment options for invasive fungal infections were limited and associated with significant toxicities. The i …
Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies.
Gea-Banacloche J. Gea-Banacloche J. Hematology Am Soc Hematol Educ Program. 2013;2013:414-22. doi: 10.1182/asheducation-2013.1.414. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319213 Review.
Hundreds of studies over the last 4 decades have produced evidence to support the following: (1) risk stratification allows the identification of a subset of patients who may be safely managed as outpatients given the right health care environment; (2) antibacterial prophy …
Hundreds of studies over the last 4 decades have produced evidence to support the following: (1) risk stratification allows the identificati …
Mucormycosis in Children: Review and Recommendations for Management.
Francis JR, Villanueva P, Bryant P, Blyth CC. Francis JR, et al. J Pediatric Infect Dis Soc. 2018 May 15;7(2):159-164. doi: 10.1093/jpids/pix107. J Pediatric Infect Dis Soc. 2018. PMID: 29294067 Review.
Mucormycosis represents the third most common invasive fungal infection in children, and recent studies have suggested a rising incidence. ...In this review, we summarize the literature on the epidemiology and diagnosis of this invasive fungal …
Mucormycosis represents the third most common invasive fungal infection in children, and recent studies have suggested …
137 results